BRISTOL MEYERS SQUIBB COMPANY v. ALEMBIC GLOBAL HOLDING SA et al
| BRISTOL MEYERS SQUIBB COMPANY |
| ALEMBIC GLOBAL HOLDING SA, ALEMBIC PHARMACEUTICALS, LTD. and ALEMBIC PHARMACEUTICALS, INC. |
| 3:2021cv17926 |
| September 30, 2021 |
| US District Court for the District of New Jersey |
| Kevin McNulty |
| Patent - Abbreviated New Drug Application(ANDA) |
| 15 U.S.C. ยง 1126 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 30, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Corporate Disclosure Statement by BRISTOL MEYERS SQUIBB COMPANY. (WALSH, LIZA) |
| Filing 1 COMPLAINT against All Defendants ( Filing and Admin fee $ 402 receipt number BNJDC-12855000), filed by BRISTOL MEYERS SQUIBB COMPANY. (Attachments: #1 Civil Cover Sheet, #2 AO120 Form)(WALSH, LIZA) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
